IL143296A0 - Use of human prostate cell lines in cancer treatment - Google Patents
Use of human prostate cell lines in cancer treatmentInfo
- Publication number
- IL143296A0 IL143296A0 IL14329699A IL14329699A IL143296A0 IL 143296 A0 IL143296 A0 IL 143296A0 IL 14329699 A IL14329699 A IL 14329699A IL 14329699 A IL14329699 A IL 14329699A IL 143296 A0 IL143296 A0 IL 143296A0
- Authority
- IL
- Israel
- Prior art keywords
- cell lines
- cancer treatment
- human prostate
- prostate cell
- derivatives
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title abstract 3
- 238000011282 treatment Methods 0.000 title abstract 2
- 210000005267 prostate cell Anatomy 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 2
- 208000007660 Residual Neoplasm Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 230000001394 metastastic effect Effects 0.000 abstract 1
- 208000037819 metastatic cancer Diseases 0.000 abstract 1
- 208000011575 metastatic malignant neoplasm Diseases 0.000 abstract 1
- 238000011269 treatment regimen Methods 0.000 abstract 1
- 239000012646 vaccine adjuvant Substances 0.000 abstract 1
- 229940124931 vaccine adjuvant Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/884—Vaccine for a specifically defined cancer prostate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9827104.2A GB9827104D0 (en) | 1998-12-10 | 1998-12-10 | New cancer treatments |
PCT/GB1999/004129 WO2000033869A2 (fr) | 1998-12-10 | 1999-12-09 | Nouveaux traitements contre le cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
IL143296A0 true IL143296A0 (en) | 2002-04-21 |
Family
ID=10843926
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14329699A IL143296A0 (en) | 1998-12-10 | 1999-12-09 | Use of human prostate cell lines in cancer treatment |
IL143296A IL143296A (en) | 1998-12-10 | 2001-05-22 | Factor containing a line of prostate cells, preparations containing it and use in the treatment of prostate cancer |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL143296A IL143296A (en) | 1998-12-10 | 2001-05-22 | Factor containing a line of prostate cells, preparations containing it and use in the treatment of prostate cancer |
Country Status (19)
Country | Link |
---|---|
US (3) | US6972128B1 (fr) |
EP (1) | EP1137422B1 (fr) |
JP (2) | JP4949554B2 (fr) |
KR (1) | KR20010090874A (fr) |
AT (1) | ATE304365T1 (fr) |
AU (1) | AU763485B2 (fr) |
CA (1) | CA2354045C (fr) |
CZ (1) | CZ300499B6 (fr) |
DE (1) | DE69927286T2 (fr) |
ES (1) | ES2249046T3 (fr) |
GB (1) | GB9827104D0 (fr) |
HU (1) | HUP0104568A3 (fr) |
IL (2) | IL143296A0 (fr) |
MX (1) | MXPA01005816A (fr) |
NO (1) | NO327044B1 (fr) |
NZ (1) | NZ512004A (fr) |
PL (1) | PL201016B1 (fr) |
WO (1) | WO2000033869A2 (fr) |
ZA (1) | ZA200104164B (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9827103D0 (en) * | 1998-12-10 | 1999-02-03 | Onyvax Ltd | New cancer treatments |
GB9827104D0 (en) * | 1998-12-10 | 1999-02-03 | Onyvax Ltd | New cancer treatments |
WO2000071156A2 (fr) * | 1999-05-21 | 2000-11-30 | Onyvax Limited | Nouvelles formulations vaccinales-3 |
WO2001075073A2 (fr) * | 2000-04-01 | 2001-10-11 | Onyvax Limited | Nouvelles lignees cellulaires prostatiques |
US6667479B2 (en) * | 2001-06-01 | 2003-12-23 | Raytheon Company | Advanced high speed, multi-level uncooled bolometer and method for fabricating same |
US20050019336A1 (en) * | 2003-07-23 | 2005-01-27 | Dalgleish Angus George | Human prostate cell lines in cancer treatment |
MXPA06002159A (es) * | 2003-08-26 | 2006-05-22 | Becton Dickinson Co | Metodos para la administracion intradermica de agentes terapeuticos. |
EP2127671B1 (fr) * | 2007-02-07 | 2016-09-14 | Nec Corporation | Agent therapeutique contre le cancer |
WO2009066462A1 (fr) * | 2007-11-20 | 2009-05-28 | Nec Corporation | Procédé pour l'induction d'un lymphocyte t cytotoxique, inducteur de lymphocyte t cytotoxique et composition pharmaceutique et vaccin comprenant chacun l'inducteur |
AU2009200767A1 (en) * | 2008-03-10 | 2009-09-24 | Aristocrat Technologies Australia Pty Limited | A gaming system and a method of gaming |
CA2743904A1 (fr) | 2008-11-17 | 2010-05-20 | The Regents Of The University Of Michigan | Compositions de vaccins contre le cancer et leurs methodes d'utilisation |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69232890T2 (de) * | 1991-10-04 | 2003-10-09 | Whitehead Biomedical Inst | Regulierung der systemischen immunantworten mittels zytokinen und antigenen |
JPH05246889A (ja) * | 1992-03-05 | 1993-09-24 | Seitai Chiyousetsu Kenkyusho:Kk | 制癌方法および制癌剤 |
AU2370195A (en) * | 1994-04-28 | 1995-11-29 | Scott Freeman | Cell lines obtained by (in vivo) migration and by fusion with autoimmune cells |
US5837233A (en) * | 1995-03-17 | 1998-11-17 | University Of California | Method for treating tumors |
US5788963A (en) * | 1995-07-31 | 1998-08-04 | Pacific Northwest Cancer Foundation | Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
ES2191784T3 (es) * | 1995-12-28 | 2003-09-16 | Univ Johns Hopkins Med | Vacunas de tumores de citocinas paracrinas alogenicas. |
CA2245099C (fr) * | 1996-02-02 | 2007-01-09 | Suzanne L. Topalian | Lignees de cellules epitheliales immortalisees provenant de prostate d'origine humaine, clones correspondants et leurs applications s'agissant de recherche et de therapie du cancer de la prostate |
GB9620350D0 (en) * | 1996-09-30 | 1996-11-13 | Maudsley David J | Cancer vaccine |
US6207805B1 (en) * | 1997-07-18 | 2001-03-27 | University Of Iowa Research Foundation | Prostate cell surface antigen-specific antibodies |
GB9827104D0 (en) * | 1998-12-10 | 1999-02-03 | Onyvax Ltd | New cancer treatments |
-
1998
- 1998-12-10 GB GBGB9827104.2A patent/GB9827104D0/en not_active Ceased
-
1999
- 1999-12-09 ES ES99959542T patent/ES2249046T3/es not_active Expired - Lifetime
- 1999-12-09 DE DE69927286T patent/DE69927286T2/de not_active Expired - Lifetime
- 1999-12-09 IL IL14329699A patent/IL143296A0/xx active IP Right Grant
- 1999-12-09 AU AU16683/00A patent/AU763485B2/en not_active Ceased
- 1999-12-09 CZ CZ20012032A patent/CZ300499B6/cs not_active IP Right Cessation
- 1999-12-09 HU HU0104568A patent/HUP0104568A3/hu unknown
- 1999-12-09 CA CA2354045A patent/CA2354045C/fr not_active Expired - Fee Related
- 1999-12-09 PL PL348828A patent/PL201016B1/pl not_active IP Right Cessation
- 1999-12-09 JP JP2000586359A patent/JP4949554B2/ja not_active Expired - Fee Related
- 1999-12-09 EP EP99959542A patent/EP1137422B1/fr not_active Expired - Lifetime
- 1999-12-09 WO PCT/GB1999/004129 patent/WO2000033869A2/fr not_active Application Discontinuation
- 1999-12-09 MX MXPA01005816A patent/MXPA01005816A/es active IP Right Grant
- 1999-12-09 US US09/857,691 patent/US6972128B1/en not_active Expired - Lifetime
- 1999-12-09 NZ NZ512004A patent/NZ512004A/en unknown
- 1999-12-09 KR KR1020017007096A patent/KR20010090874A/ko not_active Application Discontinuation
- 1999-12-09 AT AT99959542T patent/ATE304365T1/de not_active IP Right Cessation
-
2001
- 2001-05-22 ZA ZA200104164A patent/ZA200104164B/en unknown
- 2001-05-22 IL IL143296A patent/IL143296A/en not_active IP Right Cessation
- 2001-05-29 NO NO20012634A patent/NO327044B1/no not_active IP Right Cessation
-
2005
- 2005-07-12 US US11/178,415 patent/US8034360B2/en not_active Expired - Fee Related
-
2011
- 2011-10-07 JP JP2011223318A patent/JP2012021028A/ja active Pending
- 2011-10-11 US US13/270,820 patent/US20120164099A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20094798B (en) | (s,s)-reboxetine for treating chronic pain | |
MXPA04002593A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumor. | |
EP1381280A4 (fr) | Vecteurs viraux et utilisation de ces derniers dans des methodes therapeutiques | |
MXPA03011985A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumores. | |
NZ285159A (en) | Treatment of benign prostatic hyperplasia, endometriosis, prostatic carcinoma and obesity by administration of droloxifene | |
IL143296A0 (en) | Use of human prostate cell lines in cancer treatment | |
MXPA04006572A (es) | Terapia de combinacion antivirica. | |
PT967987E (pt) | Composicoes para o tratamento de tumores contendo extractos de cartilagem de tubarao e agentes antineoplasicos | |
WO2002066044A3 (fr) | Procede de traitement de tumeurs utilisant une polytherapie | |
ZA200003236B (en) | Combination therapy for the treatment of migraine. | |
AU6083301A (en) | Treating eczema and/or psoriasis | |
AU3439799A (en) | Immunization against and treatment for infection by (h.pylori) | |
DE69723580D1 (de) | Impfstoff gegen metastasierenden kolorektalkrebs. | |
IL131478A0 (en) | Methods for treatment of scar tissue | |
PL1827403T3 (pl) | Kompozycje do leczenia stanów patologicznych powierzchni oka | |
ZA200002338B (en) | Combination therapy for the treatment of migraine. | |
ZA200003235B (en) | Combination therapy for the treatment of migraine. | |
TR199802496T2 (xx) | Konjestif kalp yetmezli�ini tedavi i�in form�lasyon. | |
ES2169986A1 (es) | Uso de cdp-colina para el tratamiento profilactico de la isquemia cerebral. | |
HK1048263A1 (en) | Medicaments that contain xenogenic oligo-or/and polyribonucleotides. | |
ZA200002343B (en) | Combination therapy for the treatment of migraine. | |
AU5434899A (en) | Cancer treatment | |
MXPA02000485A (es) | 2-amino-benzoxazinonas para el tratamiento del virus de herpes simple. | |
UA33359A (uk) | Спосіб доступу до пухлин орбіти | |
ES2183734A1 (es) | Derivados de 4-4'-bipiridil-2-2'-bisoxazoles y 4-4'-bipiridil-2-2'-bistiazoles como agentes antineoplasicos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed |